title: A defect in the synthesis of Interferon-γ by the T cells of Complement-C5 deficient mice leads to enhanced susceptibility for tuberculosis.
abstract: Interferon-γ (IFNγ) plays a major role during host defense against Mycobacterium tuberculosis (Mtb). T cells produce IFNγ in response to IL-12 and IL-18 secreted from Mtb infected macrophages. IFNγ in turn, induces nitric oxide secretion in macrophages that kills Mtb. IFNγ knockout mice are thus hyper-susceptible to tuberculosis. We reported earlier that Complement-C5 deficient (C5(-/-)) congenic mice are more susceptible to tuberculosis and showed reduced IL-12 synthesis in their macrophages. Using C5(-/-) congenic mice that carry a deletion in the C5 gene and the wild type C5(+/+) mice, we demonstrate here that, the C5(-/-) derived CD3(+) T cells, have an additional defect in the synthesis of IFNγ. C5(-/-) T cells produced lower levels of IFNγ upon stimulation by antigen presenting cells (APCs) infected with Mtb or when stimulated directly with a combination of IL-12 and IL-18. The latter was in part due to a reduced phosphorylation of STAT4 following IL-12/IL-18 stimulation. Addition of C5a peptide to IL-12/IL-18 partially restored STAT4 phosphorylation and IFNγ synthesis in C5(-/-) T cells indicating that IL-12/IL-18 mediated signaling within CD3(+) T cells involves C5a peptide. Finally, C5(-/-) T cells derived from M. bovis BCG or Mtb infected mice showed a reduced expression of T-bet (T-box expressed in T cells) transcription factor, which correlated well with a reduced T cell secretion of IFNγ. Since T-bet mediated IFNγ synthesis facilitates Th1 expansion, C5(-/-) mouse derived T cells appear to have an intrinsic defect in the production of IFNγ, which is related to C5 deficiency and this may explain their increased susceptibility to infection with Mtb and BCG.
authors.affiliation: Department of Pathology and Laboratory Medicine, University of Texas Health Sciences Center, Houston, TX 77030, USA.
authors.forename: Mary Anne
authors.initials: MA
authors.lastname: Mashruwala
authors.forename: Amanda K
authors.initials: AK
authors.lastname: Smith
authors.forename: Devin R
authors.initials: DR
authors.lastname: Lindsey
authors.forename: Margaret
authors.initials: M
authors.lastname: Moczygemba
authors.forename: Rick A
authors.initials: RA
authors.lastname: Wetsel
authors.forename: John R
authors.initials: JR
authors.lastname: Klein
authors.forename: Jeffrey K
authors.initials: JK
authors.lastname: Actor
authors.forename: Chinnaswamy
authors.initials: C
authors.lastname: Jagannath
mesh_terms: D000818:Animals; D001500:BCG Vaccine / Q000276:immunology; D003182:Complement C5 / Q000172:deficiency* / Q000235:genetics / Q000276:immunology; D015936:Complement C5a / Q000276:immunology; D004198:Disease Susceptibility; D007371:Interferon-gamma / Q000096:biosynthesis* / Q000276:immunology; D018664:Interleukin-12 / Q000276:immunology; D020382:Interleukin-18 / Q000276:immunology; D008168:Lung / Q000276:immunology; D008213:Lymphocyte Activation / Q000276:immunology; D008264:Macrophages / Q000276:immunology / Q000382:microbiology; D051379:Mice; D020297:Mice, Congenic; D013154:Spleen / Q000276:immunology; D020825:T-Box Domain Proteins / Q000378:metabolism; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D014376:Tuberculosis / Q000276:immunology*; D000098815:T-bet Transcription Factor
chemical_list: D001500:BCG Vaccine; D003182:Complement C5; D020382:Interleukin-18; D020825:T-Box Domain Proteins; D000098815:T-bet Transcription Factor; D018664:Interleukin-12; D015936:Complement C5a; D007371:Interferon-gamma